Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Meta analysis on rFSH versus uFSH

H J Out, E H Hoomans, W N de Laat

    Human Reproduction (Oxford, England)
    |March 3, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments.

    Human reproduction (Oxford, England)·2001
    Same author

    A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles.

    Human reproduction (Oxford, England)·2001
    Same author

    Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation.

    Human reproduction (Oxford, England)·1999
    Same author

    Anovulatory infertility and the role of recombinant follicle-stimulating hormone (Recagon).

    Journal of the Indian Medical Association·1999
    Same author

    A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian stimulation.

    Human reproduction (Oxford, England)·1999
    Same author

    What are the clinical benefits of recombinant gonadotrophins?: the development of recombinant FSH (Puregon((R))): a scientific business.

    Human reproduction (Oxford, England)·1999
    Same journal

    ESHRE recommendations on Good Practice in the IVF laboratory†.

    Human reproduction (Oxford, England)·2026
    Same journal

    Evidence for de novo synthesis of corticosteroids in the human ovary.

    Human reproduction (Oxford, England)·2026
    Same journal

    Characterizing endometriosis and adenomyosis symptom clusters and their impact on quality of life in the All of Us Research Program.

    Human reproduction (Oxford, England)·2026
    Same journal

    A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction.

    Human reproduction (Oxford, England)·2026
    Same journal

    Subfertility in relation to gestational weight gain and gestational diabetes: the Norwegian Mother, Father and Child Cohort Study.

    Human reproduction (Oxford, England)·2026
    Same journal

    Pathogenic variants in ACTRT3 lead to male infertility characterized by fertilization defects.

    Human reproduction (Oxford, England)·2026
    See all related articles